Unresectable, Recurrent or Metastatic Melanoma
1 clinical trials · Condition
◉ Watch Unresectable, Recurrent or Metastatic Melanoma
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety and Efficacy of MGD013 in Patients With Melanoma (NCT04653038) | Zai Lab (Shanghai) Co., Ltd. | 2020-10-29 |
Track Unresectable, Recurrent or Metastatic Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.